Literature DB >> 23306816

Lower argatroban starting dose and lower aPTT goal range instead of aggressive monitoring.

Tanja Astrid Treschan1, Martin Beiderlinden.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23306816     DOI： 10.1007/s11239-012-0865-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  2 in total

1.  Bleeding risk factors associated with argatroban therapy in the critically ill.

Authors:  Bruce Doepker; Kari L Mount; Lindsay J Ryder; Anthony T Gerlach; Claire V Murphy; Gary S Philips
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

2.  Argatroban anticoagulation in critically ill patients.

Authors:  Martin Beiderlinden; Tanja A Treschan; Klaus Görlinger; Jürgen Peters
Journal:  Ann Pharmacother       Date:  2007-04-17       Impact factor: 3.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.